Hyam Levitsky - Jan 25, 2022 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
President of R&D
Signature
/s/ Michael Diem, Attorney-in-Fact
Stock symbol
IPSC
Transactions as of
Jan 25, 2022
Transactions value $
$0
Form type
4
Date filed
1/27/2022, 03:50 PM
Previous filing
Jun 17, 2021
Next filing
Apr 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IPSC Stock Option (right to buy) Award $0 +105K $0.00 105K Jan 25, 2022 Common Stock 105K $13.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.